| __timestamp | Teva Pharmaceutical Industries Limited | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9216000000 | 1717000000 |
| Thursday, January 1, 2015 | 8296000000 | 1738000000 |
| Friday, January 1, 2016 | 10044000000 | 1666000000 |
| Sunday, January 1, 2017 | 11560000000 | 1775000000 |
| Monday, January 1, 2018 | 10558000000 | 1911000000 |
| Tuesday, January 1, 2019 | 9351000000 | 1992000000 |
| Wednesday, January 1, 2020 | 8933000000 | 2057000000 |
| Friday, January 1, 2021 | 8284000000 | 2303000000 |
| Saturday, January 1, 2022 | 7952000000 | 2454000000 |
| Sunday, January 1, 2023 | 8200000000 | 2710000000 |
| Monday, January 1, 2024 | 8480000000 | 2719000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. From 2014 to 2023, Zoetis Inc. and Teva Pharmaceutical Industries Limited have shown contrasting trends in their cost of revenue. Zoetis Inc., a leader in animal health, has seen a steady increase, with costs rising by approximately 58% over the decade. This growth reflects their expanding market presence and investment in innovation. In contrast, Teva Pharmaceutical, a giant in generic drugs, experienced a 14% decline in costs, peaking in 2017. This reduction aligns with their strategic restructuring and cost-cutting measures. The data highlights Zoetis's consistent upward trajectory, while Teva's fluctuating costs suggest a focus on efficiency. These trends offer valuable insights into the strategic priorities of these pharmaceutical titans, providing a window into their operational strategies and market positioning.
Analyzing Cost of Revenue: Gilead Sciences, Inc. and Zoetis Inc.
Analyzing Cost of Revenue: Zoetis Inc. and Catalent, Inc.
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Jazz Pharmaceuticals plc
Cost of Revenue Comparison: Zoetis Inc. vs Lantheus Holdings, Inc.
Zoetis Inc. vs Mesoblast Limited: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Limited's Expenses
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Neurocrine Biosciences, Inc.
Teva Pharmaceutical Industries Limited vs Walgreens Boots Alliance, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Jazz Pharmaceuticals plc
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Grifols, S.A.'s Expenses
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Vericel Corporation
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Iovance Biotherapeutics, Inc.